MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 24 filers reported holding MARINUS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $42,000 | 0.0% | 10,000 | 0.0% | 0.01% | +14.3% |
Q1 2019 | $42,000 | +44.8% | 10,000 | 0.0% | 0.01% | +40.0% |
Q4 2018 | $29,000 | -71.0% | 10,000 | 0.0% | 0.01% | -68.8% |
Q3 2018 | $100,000 | +40.8% | 10,000 | 0.0% | 0.02% | +45.5% |
Q2 2018 | $71,000 | +86.8% | 10,000 | 0.0% | 0.01% | +83.3% |
Q1 2018 | $38,000 | -53.7% | 10,000 | 0.0% | 0.01% | -53.8% |
Q4 2017 | $82,000 | +39.0% | 10,000 | 0.0% | 0.01% | +62.5% |
Q3 2017 | $59,000 | +321.4% | 10,000 | 0.0% | 0.01% | +300.0% |
Q2 2017 | $14,000 | -22.2% | 10,000 | 0.0% | 0.00% | -33.3% |
Q1 2017 | $18,000 | +80.0% | 10,000 | 0.0% | 0.00% | +50.0% |
Q4 2016 | $10,000 | -44.4% | 10,000 | 0.0% | 0.00% | -33.3% |
Q3 2016 | $18,000 | – | 10,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SPHERA FUNDS MANAGEMENT LTD. | 1,340,588 | $1,354,000 | 0.34% |
BOOTHBAY FUND MANAGEMENT, LLC | 78,662 | $79,000 | 0.02% |
Orbimed Advisors | 567,600 | $573,000 | 0.01% |
Acrospire Investment Management LLC | 14,323 | $14,000 | 0.01% |
SHANDA ASSET MANAGEMENT HOLDINGS Ltd | 10,000 | $10,000 | 0.00% |
Virtu KCG Holdings LLC | 49,847 | $50,000 | 0.00% |
NEXT Financial Group, Inc | 2,670 | $3,000,000 | 0.00% |
Squarepoint Ops LLC | 13,000 | $13,000 | 0.00% |
FRANKLIN RESOURCES INC | 2,182,185 | $2,204,000 | 0.00% |
A.R.T. Advisors, LLC | 16,830 | $16,000 | 0.00% |